Economic Evaluation of the Fentanyl Transdermal System for the Treatment of Chronic Moderate to Severe Pain Deirdre M Neighbors, BA, Timothy J Bell,

Slides:

Advertisements

Similar presentations

Validation of the Wisconsin Brief Pain Questionnaire in a Multilingual South African Population Noko Mphahlele, MSc, Duncan Mitchell, PhD, Peter Kamerman,

Advertisements

Using a Morphine Equivalence Metric to Quantify Opioid Consumption: Examining the Capacity to Provide Effective Treatment of Debilitating Pain at the Global,

James Womer, BA, Wenjun Zhong, PhD, F. Wickham Kraemer, MD, Lynne G

Oropharyngeal Mucositis Pain Treatment with Transdermal Buprenorphine in Patients After Allogeneic Stem Cell Transplantation Samuel Vokurka, MD, PhD

An Evaluation of the Faces Pain Scale with Young Children

Transcutaneous Electrical Nerve Stimulation vs

Addressing sleep problems- The role of long-acting opioids

Neurotoxicity from Chronic Opioid Therapy After Successful Palliative Treatment for Painful Bone Metastases Andrew Broadbent, BMedSc, MBChB, FRACP, FAChPM,

Clinical Trial Results with OROS® Hydromorphone

Winston C. -V. Parris, MD, Benjamin W. Johnson, MD, Marilyn K

Transcutaneous Electrical Nerve Stimulation vs

An Effective Treatment of Severe Complex Regional Pain Syndrome Type 1 in a Child Using High Doses of Intrathecal Ziconotide Michael Stanton-Hicks, MD,

James Womer, BA, Wenjun Zhong, PhD, F. Wickham Kraemer, MD, Lynne G

Long-Term Opioid Therapy for Chronic Noncancer Pain: A Systematic Review and Meta-Analysis of Efficacy and Safety Meredith Noble, MS, Stephen J. Tregear,

Treat the Pain Program Journal of Pain and Symptom Management

Anita L Comley, PhD, RN, AOCN, Elaine DeMeyer, RN, MSN, AOCN

Fatigue in Gynecological Cancer Patients During and After Anticancer Treatment Gillian Prue, PhD, James Allen, PhD, Jacqueline Gracey, PhD, Jane Rankin,

Efficacy and Safety of the Seven-Day Buprenorphine Transdermal System in Opioid- Naïve Patients with Moderate to Severe Chronic Low Back Pain: An Enriched,

What Palliative Care-Related Problems Do Patients Experience at HIV Diagnosis? A Systematic Review of the Evidence Victoria M. Simms, MSc, Irene J. Higginson,

Consistency of Efficacy, Patient Acceptability, and Nasal Tolerability of Fentanyl Pectin Nasal Spray Compared with Immediate-Release Morphine Sulfate.

Oropharyngeal Mucositis Pain Treatment with Transdermal Buprenorphine in Patients After Allogeneic Stem Cell Transplantation Samuel Vokurka, MD, PhD

David M. Dosa, MD, MPH, David D

Safety and Effectiveness of Palliative Drug Treatment in the Last Days of Life—A Systematic Literature Review Kristian Jansen, MD, Dagny F. Haugen, MD,

The Direct and Indirect Costs of Opioid-Induced Constipation

How to Measure the International Development of Palliative Care

Morphine with Dextromethorphan

Adequacy of Opioid Analgesic Consumption at Country, Global, and Regional Levels in 2010, Its Relationship With Development Level, and Changes Compared.

Palliative Care in Romania

Transdermal Fentanyl for Chronic Pain in AIDS

The Opioid Rotation Ratio From Transdermal Fentanyl to “Strong” Opioids in Patients With Cancer Pain Akhila Reddy, MD, Sriram Yennurajalingam, MD, MS,

Parent Perceptions of Child Vulnerability Are Associated With Functioning and Health Care Use in Children With Chronic Pain Mark Connelly, PhD, Kelly.

David Clark, PhD, Michael Wright, PhD

Redefining Appropriate Treatment Expectations

Development of a symptom assessment instrument for chronic hemodialysis patients: the dialysis symptom index Steven D Weisbord, MD, Linda F Fried, MD,

Suntanu Dalal, MSc, Ronald Melzack, PhD

Transcutaneous Electrical Nerve Stimulation vs

Gender differences in the perception of chest pain

Suresh K Joishy, MD, FACP, Declan Walsh, MSc, FACP

Managing Medicines for Patients Dying at Home: A Review of Family Caregivers' Experiences Eleanor Wilson, PhD, MSc, BA, Glenys Caswell, PhD, MRes, BA,

Paul A. Sloan, MD, Dwight E. Moulin, MD, FRCP(C), Helen Hays, MD

Barrie R. Cassileth, PhD, Andrew J. Vickers, PhD

The effect of transdermal fentanyl treatment on serum cortisol concentrations in patients with non-cancer pain Emine Ozyuvaci, MD, Nergis Yanmaz Alnigenis,

Do Interference-Based Cut-Points Differentiate Mild, Moderate, and Severe Levels of 16 Cancer-Related Symptoms Over Time? Sangchoon Jeon, MS, Charles.

Strategies in Pain Management

Methadone Analgesia in Cancer Pain Patients on Chronic Methadone Maintenance Therapy Paolo L Manfredi, MD, Gilbert R Gonzales, Andrea L Cheville, Craig.

Improving Access to Opioid Analgesics for Palliative Care in India

Premedication with controlled-release oxycodone does not improve management of postoperative pain after day-case gynaecological laparoscopic surgery

Changing M3G/M6G Ratios and Pharmacodynamics in a Cancer Patient During Long- Term Morphine Treatment Gertrud Andersen, MD, Lona L Christrup, PhD, Per.

Long-Term Safety and Tolerability of Fentanyl Buccal Tablet for the Treatment of Breakthrough Pain in Opioid-Tolerant Patients with Chronic Pain: An 18-Month.

Transdermal Fentanyl in Opioid-Naive Cancer Pain Patients

Risk Factors for Common Mental Disorder in Caregiving and Bereavement

Use of Opioid Analgesics Among Older Persons With Colorectal Cancer in Two Health Districts With Palliative Care Programs Judith Fisher, BSc (Pharm),

Gertrud Andersen, MD, Lona Christrup, PhD, Per Sjøgren, MD

Pain and Policy Studies Group: Two Decades of Working to Address Regulatory Barriers to Improve Opioid Availability and Accessibility Around the World

Comparative Efficacy of Oral Extended-Release Hydromorphone and Immediate- Release Hydromorphone in Patients with Persistent Moderate to Severe Pain: Two.

Long-Term Safety of Oral Transmucosal Fentanyl Citrate for Breakthrough Cancer Pain Richard Payne, MD, Paul Coluzzi, MD, Lowell Hart, MD, Mary Simmonds,

Fentanyl for the Relief of Refractory Breathlessness: A Systematic Review Steffen T. Simon, MD, MSc, Peyla Köskeroglu, Jan Gaertner, MD, Raymond Voltz,

Iontophoretic Vincristine in the Treatment of Postherpetic Neuralgia

Microbiological and Physicochemical Stability of Oxycodone Hydrochloride Solutions for Patient-Controlled Delivery Systems Ahmed Amri, PharmD, Ahmed.

A Titrated Morphine Analgesic Regimen Comparing Substance Users and Non-Users with AIDS-Related Pain Ronald Kaplan, MD, Joseph Slywka, PhD, Susan Slagle,

Physical Function in Patients with Cancer

Steady-State Pharmacokinetic Comparison of a New, Extended-Release, Once-Daily Morphine Formulation, Avinza™, and a Twice-Daily Controlled-Release Morphine.

Pain Management, Controlled Substances, and State Medical Board Policy

Optimizing Decision Making and Resource Allocation in Palliative Care

An Evaluation of the Faces Pain Scale with Young Children

Long-Term Opioid Therapy for Chronic Noncancer Pain: A Systematic Review and Meta-Analysis of Efficacy and Safety Meredith Noble, MS, Stephen J. Tregear,

Fatigue in Gynecological Cancer Patients During and After Anticancer Treatment Gillian Prue, PhD, James Allen, PhD, Jacqueline Gracey, PhD, Jane Rankin,

A Phase I Study on the Feasibility and Acceptability of an Acupuncture/Hypnosis Intervention for Chronic Pediatric Pain Lonnie K Zeltzer, MD, Jennie.

Use of oral and transdermal opioids among patients with metastatic cancer during the last year of life Ariel Berger, MPH, Ellen Dukes, PhD, RN, Meredith.

Efficacy and Safety of the Seven-Day Buprenorphine Transdermal System in Opioid- Naïve Patients with Moderate to Severe Chronic Low Back Pain: An Enriched,

Presentation transcript:

Economic Evaluation of the Fentanyl Transdermal System for the Treatment of Chronic Moderate to Severe Pain Deirdre M Neighbors, BA, Timothy J Bell, MHA, Jerome Wilson, PhD, Sheri L Dodd, MSc Journal of Pain and Symptom Management Volume 21, Issue 2, Pages 129-143 (February 2001) DOI: 10.1016/S0885-3924(00)00247-5

Fig. 1 Opioid economic model Journal of Pain and Symptom Management 2001 21, 129-143DOI: (10.1016/S0885-3924(00)00247-5)

Fig. 2 Titration phase (up to several days) Journal of Pain and Symptom Management 2001 21, 129-143DOI: (10.1016/S0885-3924(00)00247-5)

Fig. 3 Stabilization phase (30 days) Journal of Pain and Symptom Management 2001 21, 129-143DOI: (10.1016/S0885-3924(00)00247-5)

Fig. 4 Long-term use phase (through the first year) Journal of Pain and Symptom Management 2001 21, 129-143DOI: (10.1016/S0885-3924(00)00247-5)

Fig. 5 Incremental cost-effectiveness of fentanyl transdermal system vs. controlled-release morphine and controlled-release oxycodone, varying utility of controlled pain with fentanyl transdermal system Journal of Pain and Symptom Management 2001 21, 129-143DOI: (10.1016/S0885-3924(00)00247-5)